Home / Pharma News / Caraco and Sun to merge
Caraco and Sun to merge Posted 01/04/2011
Caraco Pharmaceutical Laboratories announced on 22 February 2011 that it had entered into a merger agreement with generics manufacturer Sun Pharmaceutical Industries and its wholly-owned subsidiary Sun Pharma Global.
US-based Caraco develops markets and distributes generic pharmaceuticals to the USA’s largest wholesalers, distributors, drugstore chains and managed care providers. India’s Sun Pharma and Sun Global collectively own 75.8% of Caraco common stock. The merger agreement provides that all shareholders of Caraco other than Sun Pharma and Sun Global will receive a cash payment of US$5.25 per share upon the closing of the transaction, rather than the US$4.75 initially proposed by Sun in December 2010. The news comes despite Caraco being warned by the FDA back in September 2010 for violating manufacturing practices at its Cranbury facility in New Jersey, causing the FDA to withhold approval of pending new drug applications. Related article
Source: Caraco
Comments (0)
Sign up today to receive weekly news on the latest developments in generic and biosimilar medicines!
Generics News Research General
- Clopidogrel goes off-patent: last of the old-st...Generics/General | Posted 18/05/2012
- Generic atorvastatin could save NHS GBP 350 mil...Generics/News | Posted 18/05/2012
- Can generic competition succeed at reducing cos...Generics/Research | Posted 11/05/2012
- Also noted on generics: 11 May 2012Generics/General | Posted 11/05/2012
Biosimilars News Research General
- Biosimilar filgrastim provides cost savings for...Biosimilars/Research | Posted 11/05/2012
- US Supreme Court looks set to challenge Afforda...Biosimilars/General | Posted 18/05/2012
- Biosimilars approved and marketed in BelgiumBiosimilars/General | Posted 18/05/2012
- Daiichi Sankyo and Coherus BioSciences make bio...Biosimilars/News | Posted 18/05/2012